Invention Grant
- Patent Title: Using a blue-shifted reference dye in an optical glucose assay
-
Application No.: US15581540Application Date: 2017-04-28
-
Publication No.: US10792378B2Publication Date: 2020-10-06
- Inventor: Soren Aasmul , Jesper Svenning Kristensen
- Applicant: Medtronic MiniMed, Inc.
- Applicant Address: US CA Northridge
- Assignee: Medtronics MiniMed, Inc.
- Current Assignee: Medtronics MiniMed, Inc.
- Current Assignee Address: US CA Northridge
- Agency: Gates & Cooper LLP
- Main IPC: A61K49/00
- IPC: A61K49/00 ; G01N33/66 ; C08B37/02 ; G01N33/542 ; C08L5/02

Abstract:
The invention is directed to a competitive glucose binding affinity assay comprising a glucose receptor (typically mannan binding lectin) labeled with an assay fluorophore and a modified glucose analog (typically dextran) labeled with a reference fluorophore. In certain embodiments, the glucose analog is dextran and is coupled to both a reference fluorophore and a quencher dye (e.g. hexamethoxy crystalviolet-1). Optionally the reference fluorophore is blue shifted relative to the assay fluorophore.
Public/Granted literature
- US20180311383A1 USING A BLUE-SHIFTED REFERENCE DYE IN AN OPTICAL GLUCOSE ASSAY Public/Granted day:2018-11-01
Information query